报价延迟最少15分钟:2026/02/10 00:28 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.08 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1.13/-1.17
|
|
企业价值
29.87M
|
| 资产负债 |
|
每股账面净值
2.20
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. |
